Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Value · VanEck

VanEck Morningstar Wide Moat Value ETF (MVAL)

Ticker MVAL · Since 2024-03-26 · · Holdings as of Jun 30, 2026

Expense ratio
0.5%$50/yr per $10k
1-yr return
+14.0%as of Dec 2025
Net assets
$1.8Mall share classes
Holdings
46

Bottom line

Is MVAL a good fund? The bottom line

MVAL is a managed large value ETF from VanEck.

It charges 0.5% — about $50 a year on every $10,000 invested, cheaper than 81% of large value funds we track.

It returned +14.0% over one year (as of Dec 31, 2025, per its prospectus).

With $1.8 million in net assets and 46 holdings, its largest position is Kenvue Inc (4.8%) and the top 10 make up 40.5% of the portfolio.

What stands out

  • Low cost: cheaper than 81% of large value peers

What to watch

  • Small fund ($1.8 million) — small funds are likelier to close

Updated Nov 19, 2026

What MVAL invests in

VanEck Morningstar Wide Moat Value ETF (the Fund) seeks to track as closely as possible, before fees and expenses, the price and yield performance of the Morningstar US Broad Value Wide Moat Focus Index SM (the Index).

"Under normal circumstances, the Fund invests at least 80% of its total assets in securities that comprise the Funds benchmark index. For purposes of this policy, the term assets means net assets plus the amount of any borrowings for investment purposes. The Index is comprised of equity securities of companies that Morningstar, Inc. (Morningstar or the Index provider) determines (a) have sustainable competitive advantages based on a proprietary methodology that considers quantitative and qualitative factors (wide moat companies) and (b) are attractively priced and weighted according to a modified equal weighting scheme that tilts exposure in favor of pure value companies. According to Morningstar, value companies tend to trade at low price ratios (based on metrics like earnings, book value and sales, or high dividend yields) and have low growth rates (based on earnings, sales, book…

From the fund's prospectus (filed Jan 27, 2026).

MVAL performance

Average annual total returns
1 yr5 yr10 yr
MVAL+14.0%——
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MVAL performance history →

What MVAL costs

On a $10,000 investment, MVAL's 0.5% expense ratio costs about $50 a year. The prospectus estimates $2,294 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full MVAL fee table →

MVAL top 10 holdings

#Holding% of fund
1Kenvue Inc4.76%
2Brown-Forman Corp4.58%
3Bristol-Myers Squibb Co4.46%
4Danaher Corp4.42%
5Constellation Brands Inc4.24%
6Zimmer Biomet Holdings Inc4.22%
7Clorox Co/The4.04%
8GE HealthCare Technologies Inc3.56%
9Masco Corp3.19%
10NIKE Inc2.99%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 40.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MVAL

More funds like MVAL →

MVAL FAQ

What is the expense ratio of MVAL?
MVAL's expense ratio is 0.5%, which works out to about $50 a year for every $10,000 invested. The prospectus estimates total costs of $2,294 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MVAL a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 81% of large value peers; small fund ($1.8 million) — small funds are likelier to close. This is general information, not personalized advice.
What does MVAL hold?
MVAL's largest holdings are Kenvue Inc (4.8%), Brown-Forman Corp (4.6%), Bristol-Myers Squibb Co (4.5%), Danaher Corp (4.4%), Constellation Brands Inc (4.2%). It holds 46 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages MVAL?
MVAL is offered by VanEck through VanEck ETF Trust.